Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025
Talphera (NASDAQ: TLPH) has announced it will release its fourth quarter and full-year 2024 financial results after market close on Monday, March 31, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Talphera (NASDAQ: TLPH) has announced it will release its fourth quarter and full-year 2024 financial results after market close on Monday, March 31, 2025. The specialty pharmaceutical company, focused on developing innovative therapies for medically supervised settings, will host a live webcast and conference call at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Standard.
The webcast will feature a slide presentation and can be accessed through the company's website at www.talphera.com in the Investors/News & Events/Upcoming Events section. A replay will be available for 90 days following the event. Investors can join the conference call by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (international) using conference ID 11814.
Details
News Market Reaction – TLPH
The recorded move for TLPH in the trading session of this news was -3.11%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN MATEO, Calif., March 26, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will release fourth quarter and full-year 2024 financial results after market close on Monday, March 31, 2025, then host a live webcast and conference call at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Standard to discuss the results and provide an update on the Company's business.
Webcast Information
The webcast can be accessed here or by visiting the Investors section of the Company's website at www.talphera.com and clicking on the webcast link posted within Investors/News & Events/Upcoming Events section. The webcast will include a slide presentation and a replay will be available on the Talphera website for 90 days following the event.
Conference Call Information
Investors who wish to participate in the conference call may do so by dialing 1-800-836-8184 for North American callers, or 1-646-357-8785 (toll applies) for international callers outside of
About Talphera, Inc.
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption (IDE) as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the
This release is intended for investors only. For additional information about Talphera, please visit www.talphera.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/talphera-to-host-fourth-quarter-and-full-year-2024-financial-results-and-corporate-update-call-and-webcast-on-monday-march-31-2025-302412500.html
SOURCE Talphera, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.